Escape from HER-family tyrosine kinase inhibitor therapy by the kinase-inactive HER3Natalia Sergina, Mark M. Moasser, Byron Hann et al.|Nature|2007Cited by 991
Resiliency and Vulnerability in the HER2-HER3 Tumorigenic DriverDhara N. Amin, Mark M. Moasser, Natalia Sergina et al.|Science Translational Medicine|2010Cited by 185